Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Algeta ASA : Algeta Results for the Third Quarter 2013

02:01 EST 6 Nov 2013 | GlobalNewsWire (2014)
This article has expired, however you can still download the PDF.
Preview:
Not intended for US media Oslo, Norway, 6 November 2013 - Algeta ASA (OSE: ALGETA), a company focused on the development of novel targeted cancer therapeutics, announces its results for the third quarter 2013. A presentation of the results in Os...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Algeta ASA : Algeta Results for the Third Quarter 2013"

Search BioPortfolio:
Advertisement

Relevant Topics

Cancer Disease
Latest News Clinical Trials Research Drugs Reports Corporate
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

The Top 100 Pharmaceutical Companies
Latest News Clinical Trials Research Drugs Reports Corporate
Top 100 Pharmaceutical Companies 2012 (SCRIP 100 - http://www.scrip100.com/scrip100.html) Rank (2011 in Brackets) Company SEARCH FOR COMPANY IN BIOPORTFOLIO'S BIOCORPORATE DATABASE 2012 pharma sales...

Advertisement

Searches Linking to this Story